This podcast episode from The Economist discusses the potential risks to the Five Eyes intelligence-sharing alliance under the Trump administration, focusing on personnel changes and potential disruptions to information flow. The episode features an interview with the defense editor, who explains the close integration of intelligence agencies and the significant power the president wields over their priorities. A second segment examines China's rapid advancements in the biotech industry, highlighting its strategic investments, regulatory reforms, and "fast follower" approach to drug development, which is impacting both Western pharmaceutical companies and American biotech firms. The episode concludes with a culture segment offering curated recommendations for weekend viewing. The potential for reduced intelligence sharing between the Five Eyes nations is a key concern raised, with the expert noting that while sharing continues, the level of detail may decrease.
